{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:41:52Z","timestamp":1791283312199,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1657,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.jacc.2008.09.042","type":"journal-article","created":{"date-parts":[[2009,1,14]],"date-time":"2009-01-14T09:29:40Z","timestamp":1231925380000},"page":"221-231","source":"Crossref","is-referenced-by-count":241,"title":["Contraceptive Hormone Use and Cardiovascular Disease"],"prefix":"10.1016","volume":"53","author":[{"given":"Chrisandra L.","family":"Shufelt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Noel","family":"Bairey Merz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2008.09.042_bib1","first-page":"19","article-title":"Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth","volume":"23","author":"Chandra","year":"2005","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.jacc.2008.09.042_bib2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.fertnstert.2006.11.206","article-title":"A prospective study of oral contraceptive use and risk of myocardial infarction among Swedish women","volume":"88","author":"Margolis","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jacc.2008.09.042_bib3","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1056\/NEJMcp0708481","article-title":"Clinical practice","volume":"358","author":"Kaunitz","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib4","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1001\/archinte.1993.00410210117013","article-title":"Trends in nonfatal coronary heart disease in the United States, 1980 through 1989","volume":"153","author":"DeStefano","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0735-1097(02)02763-8","article-title":"Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study","volume":"41","author":"Bairey Merz","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2008.09.042_bib6","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jcem.87.5.8471","article-title":"Menstrual cycle irregularity and risk for future cardiovascular disease","volume":"87","author":"Solomon","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2008.09.042_bib7","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1210\/jc.2007-2025","article-title":"Reproductive history and hormonal birth control use are associated with coronary calcium progression in women with type 1 diabetes mellitus","volume":"93","author":"Snell-Bergeon","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2008.09.042_bib8","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1001\/jama.1991.03460140089033","article-title":"Estrogen and coronary heart disease in women","volume":"265","author":"Barrett-Connor","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2008.09.042_bib9","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2008.09.042_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1001\/archinte.166.3.357","article-title":"Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative","volume":"166","author":"Hsia","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib12","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","article-title":"The protective effects of estrogen on the cardiovascular system","volume":"340","author":"Mendelsohn","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib13","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1056\/NEJMe078072","article-title":"HRT and the young at heart","volume":"356","author":"Mendelsohn","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib14","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jacc.2005.10.076","article-title":"Hormone replacement therapy and the cardiovascular system: lessons learned and unanswered questions","volume":"47","author":"Ouyang","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2008.09.042_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1172\/JCI5347","article-title":"Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen","volume":"103","author":"Chen","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2008.09.042_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1113\/jphysiol.1997.sp021944","article-title":"Non-genomic mechanism of 17 beta-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle","volume":"499","author":"Kitazawa","year":"1997","journal-title":"J Physiol"},{"key":"10.1016\/j.jacc.2008.09.042_bib17","series-title":"Berek & Novak's Gynecology","author":"Stubblefield","year":"2007"},{"key":"10.1016\/j.jacc.2008.09.042_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.jacc.2008.09.042_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.jacc.2008.09.042_bib20","first-page":"2073","article-title":"Update on oral contraceptive pills","volume":"60","author":"Cerel-Suhl","year":"1999","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jacc.2008.09.042_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.contraception.2005.09.010","article-title":"Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol","volume":"73","author":"Anderson","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jacc.2008.09.042_bib22","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMcp030751","article-title":"Clinical practice","volume":"349","author":"Petitti","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.contraception.2004.09.001","article-title":"Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial","volume":"71","author":"Oddsson","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.jacc.2008.09.042_bib24","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0015-0282(01)03264-2","article-title":"A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra\/Evra)","volume":"77","author":"Sibai","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jacc.2008.09.042_bib25","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM199305273282108","article-title":"Hormonal contraception","volume":"328","author":"Baird","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-2275(20)30144-9","article-title":"Estrogen receptor-mediated repression of human hepatic lipase gene transcription","volume":"43","author":"Jones","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jacc.2008.09.042_bib27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.contraception.2007.01.027","article-title":"Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen","volume":"75","author":"Sitruk-Ware","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jacc.2008.09.042_bib28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0010-7824(01)00316-X","article-title":"An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 \u03bcg ethinyl estradiol and 100 \u03bcg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables","volume":"65","author":"Endrikat","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.jacc.2008.09.042_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.contraception.2004.08.017","article-title":"A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 \u03bcg ethinyl estradiol combined with 100 \u03bcg levonorgestrel","volume":"71","author":"Skouby","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.jacc.2008.09.042_bib30","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0010-7824(01)00269-4","article-title":"The effects of two progestogen-only pills containing either desogestrel (75 \u03bcg\/day) or levonorgestrel (30 \u03bcg\/day) on lipid metabolism","volume":"64","author":"Barkfeldt","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.jacc.2008.09.042_bib31","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","article-title":"Prospective study of oral contraceptives and hypertension among women in the United States","volume":"94","author":"Chasan-Taber","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.09.042_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0020-7292(97)00239-7","article-title":"Low-dose oral contraceptives and 24-hour ambulatory blood pressure","volume":"59","author":"Cardoso","year":"1997","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jacc.2008.09.042_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0895-7061(95)96212-3","article-title":"Ambulatory blood pressure in mild hypertensive women taking oral contraceptives","volume":"8","author":"Narkiewicz","year":"1995","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2008.09.042_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.contraception.2003.08.014","article-title":"An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone\/30 \u03bcg ethinylestradiol and 150 \u03bcg levonogestrel\/30 \u03bcg ethinylestradiol in Thai women","volume":"69","author":"Suthipongse","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jacc.2008.09.042_bib35","first-page":"1816","article-title":"Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2008.09.042_bib36","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/diacare.20.3.330","article-title":"A prospective study of oral contraceptives and NIDDM among U.S. women","volume":"20","author":"Chasan-Taber","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2008.09.042_bib37","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2337\/diacare.25.6.1027","article-title":"Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: the CARDIA study","volume":"25","author":"Kim","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2008.09.042_bib38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.maturitas.2005.05.006","article-title":"Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels","volume":"53","author":"Gol","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.jacc.2008.09.042_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.atherosclerosis.2005.06.011","article-title":"The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the Postmenopausal Estrogen Progestin Intervention (PEPI) trial","volume":"185","author":"Hu","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2008.09.042_bib40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/AOG.0b013e31816a2476","article-title":"Effects of third-generation oral contraceptives on high-sensitivity C-reactive protein and homocysteine in young women","volume":"111","author":"Cauci","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2008.09.042_bib41","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJM199011013231801","article-title":"Spinal bone loss and ovulatory disturbances","volume":"323","author":"Prior","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib42","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl 13","key":"10.1016\/j.jacc.2008.09.042_bib43","first-page":"73","article-title":"Benefits of exogenous oestrogen in inhibiting stress-related coronary artery atherosclerosis","volume":"103","author":"Clarkson","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.jacc.2008.09.042_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2004.02.010","article-title":"Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives","volume":"70","author":"Sidney","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jacc.2008.09.042_bib45","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2008.09.042_bib46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1046\/j.1526-4610.1996.3605332.x","article-title":"Migraine and angina pectoris by coronary artery spasm","volume":"36","author":"Lafitte","year":"1996","journal-title":"Headache"},{"key":"10.1016\/j.jacc.2008.09.042_bib47","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.CIR.90.2.983","article-title":"Determinants of coronary artery reactivity in premenopausal female cynomolgus monkeys with diet-induced atherosclerosis","volume":"90","author":"Williams","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.09.042_bib48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.89.1.52","article-title":"Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women","volume":"89","author":"Reis","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.09.042_bib49","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.81.5.1680","article-title":"Estrogen modulates responses of atherosclerotic coronary arteries","volume":"81","author":"Williams","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.09.042_bib50","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/01.CIR.89.6.2545","article-title":"Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women","volume":"89","author":"Gilligan","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.09.042_bib51","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/S0735-1097(99)00128-X","article-title":"Individual and combined effects of estrogen\/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease","volume":"33","author":"Herrington","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2008.09.042_bib52","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.ATV.0000126372.14332.70","article-title":"Prevention of coronary hyperreactivity in preatherogenic menopausal rhesus monkeys by transdermal progesterone","volume":"24","author":"Hermsmeyer","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2008.09.042_bib53","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1210\/jc.2004-1557","article-title":"Medroxyprogesterone acetate and dihydrotestosterone induce coronary hyperreactivity in intact male rhesus monkeys","volume":"90","author":"Mishra","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacc.2008.09.042_bib54","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.94.6.1471","article-title":"Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart","volume":"94","author":"Drici","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.09.042_bib55","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/330373a0","article-title":"Hormonal regulation of K+-channel messenger RNA in rat myometrium during oestrus cycle and in pregnancy","volume":"330","author":"Boyle","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.jacc.2008.09.042_bib56","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2006.09.054","article-title":"Long QT syndrome and pregnancy","volume":"49","author":"Seth","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2008.09.042_bib57","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM198103263041306","article-title":"Is variant angina the coronary manifestation of a generalized vasospastic disorder?","volume":"304","author":"Miller","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1472-8206.2005.00384.x","article-title":"Evidences of the gender-related differences in cardiac repolarization and the underlying mechanisms in different animal species and human","volume":"20","author":"Cheng","year":"2006","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jacc.2008.09.042_bib59","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1113\/jphysiol.2007.150367","article-title":"Acute effects of oestrogen on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization","volume":"586","author":"Kurokawa","year":"2008","journal-title":"J Physiol"},{"key":"10.1016\/j.jacc.2008.09.042_bib60","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"No. 73: use of hormonal contraception in women with coexisting medical conditions","volume":"107","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2008.09.042_bib61","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib62","first-page":"381","article-title":"Premenopausal social status and hormone exposure predict postmenopausal atherosclerosis in female monkeys","volume":"99","author":"Kaplan","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2008.09.042_bib63","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00006842-199611000-00008","article-title":"Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models","volume":"58","author":"Kaplan","year":"1996","journal-title":"Psychosom Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib64","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.15.12.2094","article-title":"Dominant social status and contraceptive hormone treatment inhibit atherogenesis in premenopausal monkeys","volume":"15","author":"Kaplan","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2008.09.042_bib65","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1172\/JCI115526","article-title":"Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys","volume":"88","author":"Wagner","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacc.2008.09.042_bib66","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/0002-9378(90)91353-E","article-title":"Oral contraceptives, lipoproteins, and atherosclerosis","volume":"163","author":"Adams","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacc.2008.09.042_bib67","first-page":"250","article-title":"Low-dose contraceptive estrogen-progestin and coronary artery atherosclerosis of monkeys","volume":"96","author":"Adams","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jacc.2008.09.042_bib68","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM198811173192004","article-title":"A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases","volume":"319","author":"Stampfer","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib69","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/bmj.298.6667.165","article-title":"Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study","volume":"298","author":"Croft","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2008.09.042_bib70","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/oxfordjournals.eurheartj.a059894","article-title":"Risk factors for acute myocardial infarction in Copenhagen, II: smoking, alcohol intake, physical activity, obesity, oral contraception, diabetes, lipids, and blood pressure","volume":"12","author":"Jensen","year":"1991","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2008.09.042_bib71","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.0954-6820.1982.tb03186.x","article-title":"Oral contraceptives, smoking and risk of myocardial infarction in young women","volume":"212","author":"Salonen","year":"1982","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jacc.2008.09.042_bib72","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bmj.318.7198.1579","article-title":"Oral contraceptives and myocardial infarction: results of the MICA case-control study","volume":"318","author":"Dunn","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2008.09.042_bib73","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","article-title":"Oral contraceptives and the risk of myocardial infarction","volume":"345","author":"Tanis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib74","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2008.09.042_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0010-7824(01)00172-X","article-title":"The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study","volume":"63","author":"Dunn","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.jacc.2008.09.042_bib76","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archinte.161.8.1065","article-title":"Low-dose oral contraceptive use and the risk of myocardial infarction","volume":"161","author":"Rosenberg","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2008.09.042_bib77","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/01.CIR.98.11.1058","article-title":"Myocardial infarction and use of low-dose oral contraceptives: a pooled analysis of 2 US studies","volume":"98","author":"Sidney","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2008.09.042_bib78","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/humrep\/17.9.2307","article-title":"Myocardial infarction and third generation oral contraceptives: aggregation of recent studies","volume":"17","author":"Spitzer","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jacc.2008.09.042_bib79","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1016\/S0002-9378(99)70696-4","article-title":"Smoking and use of oral contraceptives: impact on thrombotic diseases","volume":"180","author":"Lidegaard","year":"1999","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2008.09.042_bib80","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.fertnstert.2004.07.135","article-title":"Adverse cardiovascular disease outcomes are reduced in women with a history of oral contraceptive use: results from the Women's Health Initiative database","volume":"82","author":"Victory","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jacc.2008.09.042_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.eurheartj.a061365","article-title":"Coronary atherosclerosis and myocardial infarction in young women\u2014role of oral contraceptives","volume":"4","author":"Engel","year":"1983","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2008.09.042_bib82","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0002-9378(90)90569-S","article-title":"Past use of oral contraceptives and cardiovascular disease: a meta-analysis in the context of the Nurses' Health study","volume":"163","author":"Stampfer","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jacc.2008.09.042_bib83","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.fertnstert.2006.01.009","article-title":"Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation","volume":"85","author":"Merz","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jacc.2008.09.042_bib84","first-page":"1373","article-title":"Oral contraceptive use during the perimenopausal years","volume":"58","author":"Van Winter","year":"1998","journal-title":"Am Fam Physician"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109708034888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109708034888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T21:34:54Z","timestamp":1632951294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109708034888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0735109708034888"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2008.09.042","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}